Prostate Specific Antigen (PSA)

PSA Testing Found to Reduce Prostate Cancer Mortality

Delicia Honen Yard August 19, 2010

Deaths from prostate cancer (PCa) fell by almost half after 14 years of biennial screening, according to data from a Swedish study.
 

PSA Rises More Slowly with Age in Diabetics

Jody A. Charnow June 03, 2010

SAN FRANCISCO—Men with diabetes experience significantly smaller increases in PSA level as they age compared with non-diabetics, according to findings reported here at the American Urological Association Annual Meeting.
 

PSA Doubling Time Predicts Survival After PSA Failure

Jody A. Charnow April 26, 2010

SAN FRANCISCO—PSA doubling time (PSADT) is the most important predictor of 15-year overall survival among men who experience biochemical recurrence after radical prostatectomy for prostate cancer, according to a study.
 

PSA Lower in Aspirin-Using Never Smokers

Jody A. Charnow April 01, 2010

Aspirin use is associated with lower PSA levels in men who have never smoked, data suggest.
 

PCA3 Beats PSA in Predicting Prostate Biopsy Outcomes

Jody A. Charnow March 05, 2010

SAN FRANCISCO—The prostate cancer gene 3 (PCA3) molecular urine test is more accurate than the PSA test in predicting outcomes of repeat biopsies, new findings confirm.
 

PSA Levels Decline After The Start of Statin Therapy

Jody A. Charnow January 15, 2010

Onset of statin use is associated with a significant reduction in serum PSA level, data suggest.
 

PSA Testing Rate Highest in Blacks

Jody A. Charnow December 15, 2009

A study of a large multiethnic cohort found that African-American men had a higher prevalence of PSA screening than white and Latino men.
 

Undetectable PSA Possible With Radiation

John Schieszer December 10, 2009

After a median of 32 months, PSA was undetectable in 12% of patients.
 

BMI Affects PSA Test Results in Whites

Jody A. Charnow September 18, 2009

The likelihood of an abnormal finding is 46% lower in obese men than normal-weight men, study shows
 

PSM Site Predicts PSA Relapse Risk

Jody A. Charnow September 17, 2009

Positive margins at the prostate base are associated with the worst outcomes.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions